Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases

Oriana M. Damas; Maria T. Abreu

doi:10.1016/j.cgh.2019.11.027

Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases

Oriana M. Damas, Maria T. Abreu

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	1433-1435
Number of pages	3
Journal	Clinical Gastroenterology and Hepatology
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/j.cgh.2019.11.027
State	Published - Jun 2020
Externally published	Yes

Access to Document

10.1016/j.cgh.2019.11.027

Cite this

@article{04b9cb4fd0224674b0efd8a96cd017eb,

title = "Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases",

author = "Damas, {Oriana M.} and Abreu, {Maria T.}",

note = "Funding Information: Conflicts of interest This author discloses the following: Maria T. Abreu has received grant and/or research support from Prometheus Laboratories, Takeda, and Pfizer, has served as a consultant for AbbVie Laboratories, Prometheus Laboratories, Takeda, Janssen Pharmaceuticals, Focus Medical Communications, Celgene Corporation, Eli Lilly Pharmaceuticals, Pfizer, Shire Pharmaceuticals, Roche Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Amgen, Gilead, and Allergan, and has served on the speaker{\textquoteright}s bureau for Takeda and Focus Medical Communications. The remaining author discloses no conflicts. Funding Information: Conflicts of interest This author discloses the following: Maria T. Abreu has received grant and/or research support from Prometheus Laboratories, Takeda, and Pfizer, has served as a consultant for AbbVie Laboratories, Prometheus Laboratories, Takeda, Janssen Pharmaceuticals, Focus Medical Communications, Celgene Corporation, Eli Lilly Pharmaceuticals, Pfizer, Shire Pharmaceuticals, Roche Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Amgen, Gilead, and Allergan, and has served on the speaker's bureau for Takeda and Focus Medical Communications. The remaining author discloses no conflicts.",

year = "2020",

month = jun,

doi = "10.1016/j.cgh.2019.11.027",

language = "English",

volume = "18",

pages = "1433--1435",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders",

number = "7",

}

TY - JOUR

T1 - Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases

AU - Damas, Oriana M.

AU - Abreu, Maria T.

N1 - Funding Information: Conflicts of interest This author discloses the following: Maria T. Abreu has received grant and/or research support from Prometheus Laboratories, Takeda, and Pfizer, has served as a consultant for AbbVie Laboratories, Prometheus Laboratories, Takeda, Janssen Pharmaceuticals, Focus Medical Communications, Celgene Corporation, Eli Lilly Pharmaceuticals, Pfizer, Shire Pharmaceuticals, Roche Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Amgen, Gilead, and Allergan, and has served on the speaker’s bureau for Takeda and Focus Medical Communications. The remaining author discloses no conflicts. Funding Information: Conflicts of interest This author discloses the following: Maria T. Abreu has received grant and/or research support from Prometheus Laboratories, Takeda, and Pfizer, has served as a consultant for AbbVie Laboratories, Prometheus Laboratories, Takeda, Janssen Pharmaceuticals, Focus Medical Communications, Celgene Corporation, Eli Lilly Pharmaceuticals, Pfizer, Shire Pharmaceuticals, Roche Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Amgen, Gilead, and Allergan, and has served on the speaker's bureau for Takeda and Focus Medical Communications. The remaining author discloses no conflicts.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85085012919&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2019.11.027

DO - 10.1016/j.cgh.2019.11.027

M3 - Editorial

C2 - 31751772

AN - SCOPUS:85085012919

SN - 1542-3565

VL - 18

SP - 1433

EP - 1435

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 7

ER -